CA 19-9
A tumour marker associated with pancreatic and biliary cancers, used for monitoring known disease.
Same honest caveat as all tumour markers: not a screening test. It's elevated in many benign conditions and normal in some cancers — and roughly 5–10% of people genetically can't produce it at all.
Optimal ranges, root causes, and the complete correction protocol — nutrition, supplements, lifestyle, hormones and peptides — plus 100+ other markers.
Unlock everything — $10/mo →📚 NCCN guidance — CA 19-9 in pancreatic cancer monitoring, not screening.
🩸 Test your CA 19-9
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 102 markers →What CA 19-9 is usually tested alongside
On its own, one marker is a data point. These panels include CA 19-9 plus the markers that make it interpretable — each names every test, why it is on the list, and loads the whole set into your cart in one click at 10% off.
includes this + 12 more markers — Healthy, asymptomatic, and want the most informative baseline you can get — the panel to run once a year and track for decades.
includes this + 6 more markers · built for men — Never had proper bloodwork, or want the highest-value snapshot for the least money.
includes this + 6 more markers · built for women — Never had proper bloodwork, or want the highest-value snapshot for the least money.
Why your CA 19-9 might be wrong
Most abnormal results are interference, not disease. These are the things that measurably move this specific marker — check them before you change anything. Each one says whether the number is wrong and should be repeated, badly timed and should be redrawn, or real with a cause worth explaining.
Roughly 5–10% of people genetically cannot produce CA 19-9 at all. In them the marker reads near-zero even with advanced disease — a false reassurance rather than a false alarm.
A very low CA 19-9 does not exclude anything if you are Lewis-negative.
Any cause of blocked bile ducts raises CA 19-9 markedly, including entirely benign gallstones.
Interpret alongside bilirubin and ALP.
What CA 19-9 means in combination
A single marker tells you a little. Combinations tell you the story — these are the named patterns this marker takes part in, and what each one points at.
Tumour markers are monitoring tools, not screening tests, and every one of them rises in benign conditions. CA-125 with endometriosis, fibroids or any peritoneal irritation. CEA with smoking. CA 19-9 with gallstones and any biliary obstruction. Calcitonin with chronic PPI use and kidney impairment.
Interpret only in context, and never as a screen. The trend across serial measurements matters far more than one value.
Roughly 5–10% of people genetically cannot produce CA 19-9 at all. In them the marker reads near-zero even with advanced disease — which makes this the rare tumour marker whose failure mode is false reassurance rather than a false alarm.
A very low CA 19-9 does not exclude anything if you are Lewis-negative. Any real clinical suspicion needs imaging regardless of the number.
What to test next
Markers rarely answer alone. These are the ones that put CA 19-9 in context — each with its own full breakdown.
Frequently asked questions
<35 U/mL Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Optimal ranges, root causes and the full correction protocol are available inside Coach Cam's Peptide Academy.
See the full breakdown inside the Academy.
See the full breakdown inside the Academy.
You can order CA 19-9 directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.